2023-08-02
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting
2023-02-28
Arbele has entered a joint venture with the Chinese Manufacturers’ Association of Hong Kong (CMA) with a vision to establish accredited cell banking facilities in Hong Kong and Greater Bay Areas
2022-10-24
Arbele CEO Dr. John Luk, attended and presented at the Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship in Washington DC, USA
2022-09-28
嘉立醫療科技於2022年港澳台創新創業大賽榮獲二等獎 / Caleb won 2nd prize at Hong Kong, Macao and Taiwan Innovation and Entrepreneurship Competition 2022
2022-04-11
Arbele has been Inducted in the Hong Kong Tech 300 Angel Fund Program
2022-04-03
Arbele Diagnostic Lab at CMA has Acquired the ISO9001 Accreditation
2021-04-07
Arbele Receives AFCR BRACE Award Investment Funding
2021-03-31
Arbele has Successfully Completed the Incu-Bio Programme of HKSTP
2020-12-04
HKSTP Biotechnology Companies Sanomics and Arbele Enter into a Strategic Partnership to Accelerate Cancer Treatment Development
2020-11-17
CAR-TCR Asia Summit